
Older patients who are diagnosed with HIV/AIDS present a variety of challenges for providers, especially when it comes to controlling their costs of care.

Older patients who are diagnosed with HIV/AIDS present a variety of challenges for providers, especially when it comes to controlling their costs of care.

Jardiance, which was approved in Europe in May of this year, was late in coming because of certain issues raised by the FDA at Boerhringer's manufacturing plant.

With diabetes costs taking double-digit increases--and expensive newer meds launching--insurers are tightening restrictions on drug use.

ADA 74th Scientific Sessions

ADA 74th Scientific Sessions

ADA 74th Scientific Sessions


ADA 74th Scientific Sessions

On the second day of "Patient-Centered Diabetes Care: Putting Theory Into Practice," Jan Berger, MD, MJ, president of Health Intelligence Partners, moderated the panel discussion "Measuring the Impact of Pharmacists in Diabetes Patient Care."

Joyce furthered the discussion on the role of pharmacists in patient-care started by Haydon-Greatting by providing case studies that stemmed out of a CMS-funded research grant.

Dr. Vojta emphasized the importance of analyzing existing good patient data to improve care outcomes.

As part of its mission to bring together stakeholders engaged in implementing the Affordable Care Act, The American Journal of Managed Care created the ACO and Emerging Healthcare Delivery Coalition, which gives participants opportunities to share best practices in using new reimbursement models. The final panel of "Patient-Centered Diabetes Care: Putting Theory Into Practice" invited ACO Coalition members to present insights on diabetes care.

The panel discussion for Session 3, "The Role of Health Plans and Payers in Patient Care," discussed the role of payers in revolutionizing the system to make it patient-centric.

Pearson emphasized a coordination of care, between the primary care provider, the pharmacist, and payers, to improve patient care.

During her presentation, Haydon-Greatting who has trained as a pharmacist, talked about the influential role that a pharmacist could play in patient care and disease management.

Information technology will be crucial to pushing disease prevention efforts in healthcare.


Accountable care is forcing providers to develop new capacities and strategies for managing cost and quality trends. Prospectively managing the health of populations requires shifting the focus of care delivery from episodic interventions to continuous population management. As a result, accountable care organizations (ACOs) are dedicating considerable focus to developing the infrastructure and tools needed to help patients manage their chronic conditions. This is a significant departure from traditional care-delivery models and will require provider organizations to develop new partnerships and embrace new methods.




Peer Exchange: Recorded during Patient-Centered Diabetes Care, Princeton, N.J., April 10, 2014.




259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
